Clinical Trial Update: DETERMINE Trial Treatment Arm 04: Trastuzumab in Combination With Pertuzumab in Adult, Paediatric and Teenage/Young Adult Patients With Cancers With HER2 Amplification or Activating Mutations [Phase 2, Phase 3]

View source ↗

Summary

The DETERMINE trial update investigates the combination of Trastuzumab and Pertuzumab for HER2-amplified or activating-mutant cancers in adults and younger pati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Colorectal Cancer
• Gallbladder Cancer
• Lung Cancer
• Ovarian Cancer
• Pancreatic Cancer
• Prostate Cancer
• Skin Cancer

Drugs mentioned

• HERCEPTIN (trastuzumab)
• Perjeta (pertuzumab)

Snippet

Sponsor: Cancer Research UK | Conditions: Haematological Malignancy, Colorectal Neoplasms | Phase 2, Phase 3 | Status: RECRUITING